Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 20 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

2 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

10 recruiting

Enrollment Performance

Analytics

N/A
4(33.3%)
Phase 2
4(33.3%)
Phase 1
2(16.7%)
Phase 3
1(8.3%)
Phase 4
1(8.3%)
12Total
N/A(4)
Phase 2(4)
Phase 1(2)
Phase 3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT06597227Not ApplicableRecruiting

Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy

Role: collaborator

NCT05871099Phase 3Recruiting

Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not

Role: collaborator

NCT05917379Phase 1Completed

The Efficacy and Safty of FMT in Patients With CID

Role: collaborator

NCT07337564Phase 2Not Yet Recruiting

A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum

Role: lead

NCT07157631Not ApplicableRecruiting

Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial

Role: collaborator

NCT05674097Completed

Blood Flow Path Reconstruction in Rectal Cancer

Role: lead

NCT06341998Phase 2Completed

Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children

Role: lead

NCT06470464Phase 2Completed

Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor

Role: lead

NCT07154316Phase 2Recruiting

Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer

Role: collaborator

NCT06900010Phase 1Recruiting

A Study to Evaluate CM336 in Adults with Autoimmune Bullous Disease

Role: lead

NCT06662071Recruiting

A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology

Role: collaborator

NCT06649422Not Yet Recruiting

Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study

Role: collaborator

NCT06171061Phase 4Recruiting

Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome

Role: lead

NCT06028516Unknown

MRD Application in Colorectal Cancer Patients

Role: lead

NCT05684328Not ApplicableRecruiting

Narrow Band Imaging Versus White Light for the Detection and Miss of Sessile Serrated Lesion

Role: collaborator

NCT05129904Unknown

Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)

Role: collaborator

NCT06040229Completed

Retrospective Study in FFPE Samples From Younger Patients With Rhabdomyosarcoma

Role: lead

NCT05699629Recruiting

Prospective Coronary Heart Disease Cohort

Role: lead

NCT05719545Recruiting

A Cohort of Patients Undergoing Percutaneous Coronary Intervention

Role: collaborator

NCT05030376Not ApplicableCompleted

Intraileal Glucose vs. Saline Infusion on Hormone Secretion and Glycemic Excursions

Role: collaborator

All 20 trials loaded